A Study to Evaluate the Safety of Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product StromaForte for the Treatment of Knee Osteoarthritis

NCT06084988 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteo Arthritis Knee

Interventions

BIOLOGICAL: Human Allogenic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte)

Sponsor

Cellcolabs Clinical SPV Limited

Collaborators

[object Object]